(Q44095673)

29 November 2017

title

Residual symptoms after remission of major depressive disorder with fluoxetine and risk of relapse (English)

1 reference

major depressive disorder

29 November 2017

main subject

1 reference

1 reference

Nadia Iovieno

1

1 reference

29 November 2017

Adrienne van Nieuwenhuizen

2

1 reference

29 November 2017

Alisabet Clain

3

1 reference

29 November 2017

Lee Baer

4

1 reference

29 November 2017

Andrew A Nierenberg

5

1 reference

29 November 2017

publication date

13 December 2010

1 reference

29 November 2017

published in

Depression and Anxiety

1 reference

29 November 2017

volume

28

1 reference

29 November 2017

issue

2

1 reference

29 November 2017

page(s)

137-144

1 reference

Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report

29 November 2017

cites work

1 reference

Major depressive disorder: a prospective study of residual subthreshold depressive symptoms as predictor of rapid relapse.

21 January 2018

1 reference

Does incomplete recovery from first lifetime major depressive episode herald a chronic course of illness?

21 January 2018

1 reference

The role and clinical significance of subsyndromal depressive symptoms (SSD) in unipolar major depressive disorder

21 January 2018

1 reference

Major depressive subtypes and treatment response

21 January 2018

1 reference

Clinical characteristics and treatment outcome in a representative sample of depressed inpatients - findings from the Munich Antidepressant Response Signature (MARS) project

21 January 2018

1 reference

A rating scale for depression

21 January 2018

1 reference

21 January 2018

2 references

21 January 2018

7 January 2021

Primary insomnia: a risk factor to develop depression?

1 reference

Sleep disturbance and psychiatric disorders: a longitudinal epidemiological study of young adults

21 January 2018

1 reference

Effect of fluoxetine on sleep

21 January 2018

1 reference

The effects of fluoxetine on the polysomnogram of depressed outpatients: a pilot study

21 January 2018

1 reference

Fluoxetine-induced sleep disturbance in depressed patients.

21 January 2018

1 reference

Comparative effects of mirtazapine and fluoxetine on sleep physiology measures in patients with major depression and insomnia

21 January 2018

2 references

21 January 2018

7 January 2021

Major depression symptoms in primary care and psychiatric care settings: a cross-sectional analysis

1 reference

Residual anxiety symptoms in depressed primary care patients

21 January 2018

1 reference

A double-blind comparison of sexual functioning, antidepressant efficacy, and tolerability between agomelatine and venlafaxine XR.

21 January 2018

1 reference

Long-term social functioning after depression treated by psychiatrists: a review

21 January 2018

1 reference

Evidence for continuing neuropsychological impairments in depression.

21 January 2018

1 reference

A review of studies of the Hamilton depression rating scale in healthy controls: implications for the definition of remission in treatment studies of depression

21 January 2018

1 reference

Residual symptoms after partial remission: an important outcome in depression

21 January 2018

1 reference

7 January 2021

The treatment of chronic depression, part 3: psychosocial functioning before and after treatment with sertraline or imipramine.

1 reference

7 January 2021

The concept of recovery in major depression

1 reference

7 January 2021

Clinical factors associated with treatment resistance in major depressive disorder: results from a European multicenter study.

1 reference

7 January 2021

Combined Dexamethasone/Corticotropin Releasing Hormone Test Predicts Treatment Response in Major Depression–A Potential Biomarker?

1 reference

7 January 2021

Predictors of Relapse in a Prospective Study of Fluoxetine Treatment of Major Depression

1 reference

7 January 2021

A comparison of rates of residual insomnia symptoms following pharmacotherapy or cognitive-behavioral therapy for major depressive disorder.

1 reference

7 January 2021

Prevalence, course, and comorbidity of insomnia and depression in young adults.

1 reference

7 January 2021

A Multicenter, Double-Blind Comparison of the Effects of Nefazodone and Fluoxetine on Sleep Architecture and Quality of Sleep in Depressed Outpatients

1 reference

7 January 2021

Prevalence of anxiety disorders and their comorbidity with mood and addictive disorders

1 reference

7 January 2021

Cognitive behavioral treatment of residual symptoms in primary major depressive disorder

1 reference

7 January 2021

Treating impulsivity and anxiety in the suicidal patient

1 reference

7 January 2021

Efficacy of venlafaxine extended release in patients with major depressive disorder and comorbid generalized anxiety disorder

1 reference

7 January 2021

Anxious depression in elderly patients. Response to antidepressant treatment

1 reference

7 January 2021

Prevalence of sexual dysfunction among newer antidepressants.

1 reference

7 January 2021

Sexual dysfunction before antidepressant therapy in major depression

1 reference

7 January 2021

Identifiers

DOI

10.1002/DA.20768

1 reference

release_f54svmynrva2riwsio57kvnyau

29 November 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/f54svmynrva2riwsio57kvnyau

24 November 2022

mapped directly with Wikidata item

1 reference